intracranial embolism: Blocking of a blood vessel in the skull by an embolus which can be a blood clot (thrombus) or other undissolved material in the blood stream. Most emboli are of cardiac origin and are associated with heart diseases. Other non-cardiac sources of emboli are usually associated with vascular diseases.
Occlusion and stenosis of arteries, not leading to stroke
DOID EFO Endpoint Browser PheWeb
I9_STENOSIS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
551 |
4. Check minimum number of eventsNone |
551 |
5. Include endpointsNone |
551 |
6. Filter based on genotype QC (FinnGen only) |
551 |
Control definitions (FinnGen only)
- Control exclude
- I9_CEREBVASC
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- I60-I69
- Name in latin
- Occlusio sive stenosis arteriarum cerebralium sine infarctu
Similar endpoints
↥List of similar endpoints to
Occlusion and stenosis of arteries, not leading to stroke
based on the number of shared cases.
Similar with more cases:
- Cerebrovascular diseases (FINNGEN)
- Cerebrovascular diseases
- Neurological diseases, wide definition
- Cardiovascular diseases (excluding rheumatic etc)
- Cardiovascular diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7018 | 2849 | 3990 |
| Only index persons | 3710 | 1691 | 2019 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.10 | 0.08 | 0.11 |
| Only index persons | 0.07 | 0.06 | 0.08 |
| Median age at first event (years) | |||
| Whole population | 67.81 | 70.75 | 65.76 |
| Only index persons | 65.92 | 68.76 | 63.54 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 551 | 177 | 374 |
| Unadjusted period prevalence (%) | 0.13 | 0.06 | 0.16 |
| Median age at first event (years) | 62.80 | 62.67 | 62.86 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 506
- Matched controls
- 5058
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
4331X
ICD-9 Finland
Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS SINE INFARCTU CEREBR]
+∞
235.4
207
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
247.3
157.9
155
9
5541
FHL
Subclavia and / or carotid endarterectomy, reconstruction or bypass surgery
+∞
139.2
127
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
348.7
134.2
130
5
I66.9
ICD-10 Finland
Occlusion and stenosis of unspecified cerebral artery
1256.2
107.5
101
*
B01AC07
ATC
dipyridamole; systemic
10.6
72.9
155
203
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
676.5
62.2
60
*
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
663.7
61.1
59
*
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
11.2
52.9
105
115
G46.0*I66.0
ICD-10 Finland
Middle cerebral artery syndrome
+∞
42.3
40
*
I66.0
ICD-10 Finland
Occlusion and stenosis of middle cerebral artery
+∞
41.2
39
*
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
6.6
38.1
106
195
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
+∞
34.8
33
*
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
34.8
33
*
4351A
ICD-9 Finland
Transient cerebral ischaemia, Vertebral artery syndrome
68.3
33.5
38
6
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
344.3
32.2
32
*
4331A
ICD-9 Finland
Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS CUM INFARCTU CEREBRI]
+∞
30.5
29
*
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
159.1
29.0
30
*
AA1AD
NOMESCO Finland
CT of head and brain
3.2
23.8
151
594
B01AC04
ATC
clopidogrel; oral
3.2
23.0
140
534
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.5
22.6
122
425
I66.8
ICD-10 Finland
Occlusion and stenosis of other cerebral artery
+∞
22.0
21
*
G46.2*I66.2
ICD-10 Finland
Posterior cerebral artery syndrome
+∞
21.0
20
*
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
8.3
20.1
45
59
I66.3
ICD-10 Finland
Occlusion and stenosis of cerebellar arteries
+∞
19.9
19
*
4339X
ICD-9 Finland
Occlusion and stenosis of precerebral arteries, Unspecified precerebral artery[OCCL/STENOSIS ARTER.PRAECEREBRALES NUD SINE INFARCT]
+∞
19.9
19
*
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
+∞
19.9
19
*
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
8.4
18.2
40
51
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
+∞
17.8
17
*
K90
ICPC
Stroke/cerebrovascular accident
16.4
17.7
28
18
4402A
ICD-9 Finland
Atherosclerosis, Of native arteries of the extremities
6.8
17.0
43
68
I66.2
ICD-10 Finland
Occlusion and stenosis of posterior cerebral artery
+∞
16.8
16
*
C10AX09
ATC
ezetimibe; oral
4.0
16.0
67
186
205
Kela drug reimbursment
Chronic hypertension
2.2
15.6
227
1363
B01AA03
ATC
warfarin; systemic
2.3
14.9
185
1026
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
6.6
14.9
38
61
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
+∞
14.7
14
*
XA800
NOMESCO Finland
Neuropsychological investigation
10.9
14.4
27
26
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.1
13.8
55
146
C10AA05
ATC
atorvastatin; oral
2.1
13.7
205
1225
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
+∞
13.6
13
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.8
13.1
37
68
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.1
13.0
190
1120
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.1
12.9
215
1336
C10AA01
ATC
simvastatin; oral
2.0
12.7
265
1794
I66.4
ICD-10 Finland
Occlusion and stenosis of multiple and bilateral cerebral arteries
+∞
12.5
12
*
4330X
ICD-9 Finland
Occlusion and stenosis of precerebral arteries, Basilar artery[OCCL/STENOS ART.VERTEBRAL.SEU BASILAR.SINE INFARCTU]
+∞
12.5
12
*
4350A
ICD-9 Finland
Transient cerebral ischaemia, Basilar artery syndrome
38.6
12.3
15
*
4019X
ICD-9 Finland
Essential hypertension, Unspecified
4.0
12.0
48
128
I66.1
ICD-10 Finland
Occlusion and stenosis of anterior cerebral artery
+∞
11.5
11
*
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
+∞
11.5
11
*
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
+∞
11.5
11
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
122.7
11.5
12
*
5651
FHL
Reoperation due to wound complication
122.7
11.5
12
*
R47.0
ICD-10 Finland
Dysphasia and aphasia
25.7
11.2
15
6
C08DB01
ATC
diltiazem; oral
2.8
10.7
72
282
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.3
10.6
114
575
C09AA02
ATC
enalapril; systemic
2.1
10.6
147
832
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.9
10.6
194
1225
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
+∞
10.4
10
*
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.9
10.3
33
71
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
8.7
10.1
21
25
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
2.5
9.9
85
383
R42
ICD-10 Finland
Dizziness and giddiness
2.1
9.8
126
687
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.9
9.7
183
1161
N03AF02
ATC
oxcarbazepine; oral
8.3
9.4
20
25
PA2VT
NOMESCO Finland
Intravascular evacuation of brain artery embolus
+∞
9.4
9
*
I65.3
ICD-10 Finland
Occlusion and stenosis of multiple and bilateral precerebral arteries
+∞
9.4
9
*
C03CA01
ATC
furosemide; systemic
1.8
9.2
242
1709
B04AB01
ATC
NA
5.2
9.1
27
54
4409X
ICD-9 Finland
Atherosclerosis, Generalised and unspecified atherosclerosis
15.9
9.1
14
9
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
5.7
9.0
25
46
C08CA01
ATC
amlodipine; oral
1.8
8.9
202
1357
315
Kela drug reimbursment
Clopidogrel
11.0
8.8
16
15
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.6
8.8
68
290
4408X
ICD-9 Finland
Atherosclerosis, Of other specified arteries
+∞
8.4
8
*
AAL10
NOMESCO Finland
Intracranial endovascular thrombolysis
+∞
8.4
8
*
N18
ICPC
Paralysis/weakness
11.0
8.3
15
14
B04AB02
ATC
NA
4.0
8.2
32
85
A06AD11
ATC
lactulose; oral
2.0
8.2
113
632
41399
ICD-8 Finland
Angina pectoris, Without mention of hypertensive disease
5.0
8.2
25
52
C01DA14
ATC
isosorbide mononitrate; oral
1.8
8.0
154
974
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
2.2
7.8
79
387
I67.2
ICD-10 Finland
Cerebral atherosclerosis
45.7
7.7
9
*
11
HP
Coronary artery bypass surgery
3.3
7.6
37
118
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
18.7
7.6
11
6
H53.4
ICD-10 Finland
Visual field defects
7.3
7.5
17
24
R51.80
ICD-10 Finland
Headache
2.6
7.5
54
221
4341A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral embolism
+∞
7.3
7
*
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
+∞
7.3
7
*
G46.1*I66.1
ICD-10 Finland
Anterior cerebral artery syndrome
+∞
7.3
7
*
4349A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral artery occlusion, unspecified[OCCL/STENOS ARTER.CEREBRALES NUD CUM INFARCTU CEREB]
+∞
7.3
7
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
30.5
7.2
9
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
10.2
7.1
13
13
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
7.0
127
778
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.4
6.9
59
263
C02DE04
ATC
NA
2.8
6.9
44
168
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
4.9
6.9
21
44
C08CA05
ATC
nifedipine; systemic
2.4
6.8
57
255
G45.3
ICD-10 Finland
Amaurosis fugax
5.4
6.8
19
36
4130X
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]
3.1
6.8
36
123
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
2.6
6.8
47
189
N06AB04
ATC
citalopram; systemic
1.9
6.8
99
563
I63.8
ICD-10 Finland
Other cerebral infarction
40.6
6.8
8
*
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
40.6
6.8
8
*
AA5PD
NOMESCO Finland
CT examination of brain pefusion
40.6
6.8
8
*
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.7
6.7
44
173
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.9
6.6
96
546
K89
ICPC
Transient cerebral ischaemia
10.2
6.6
12
12
PA6AD
NOMESCO Finland
CT of neck arteries
10.2
6.6
12
12
81
HP
Angiography of the heart and coronary arteries
2.2
6.5
68
335
SPAT1252
SPAT
Overall medication plan or its review
2.5
6.5
51
219
5314
FHL
Bypass surgery for four or more vessels
4.4
6.5
22
52
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.9
6.5
38
139
N02AX02
ATC
tramadol; systemic, rectal
1.6
6.4
201
1447
N03AX16
ATC
pregabalin; oral
1.9
6.4
96
550
R06.0
ICD-10 Finland
Dyspnoea
1.8
6.4
129
819
B01AC06
ATC
acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)
2.3
6.3
55
250
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
+∞
6.3
6
*
G46.0
ICD-10 Finland
Middle cerebral artery syndrome
+∞
6.3
6
*
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
+∞
6.3
6
*
C02DE02
ATC
NA
3.5
6.2
27
80
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.5
6.2
27
80
N03AF01
ATC
carbamazepine; oral, rectal
3.1
6.2
32
108
N05CF01
ATC
zopiclone; oral
1.6
6.1
174
1221
5253
FHL
Cardiac lung machine
4.7
6.0
19
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018677) aPTT in Platelet poor plasma by Coagulation assay
110
510
2.45
14.33
2.1
1.9
s
29.0
30.0
1.32
110
486
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
158
1025
1.76
7.75
2.7
1.9
u/l
135.5
343.7
1.85
153
938
(3044290) Cell count panel - Cerebral spinal fluid
17
36
4.84
7.68
1.7
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
49
245
2.10
5.23
2.6
3.1
g/l
121.0
125.8
0.76
49
239
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
19
5.34
5.05
1.8
1.3
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
9
9
10.14
5.04
1.9
1.1
mmol/l
2.5
2.0
—
9
9
(3032080) INR in Blood by Coagulation assay
213
1645
1.48
4.62
14.4
12.0
inr
1.4
1.4
0.36
82
469
(3016018) Differential panel - Cerebral spinal fluid
9
14
6.51
3.99
1.3
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
243
2902
0.71
3.83
27.4
17.9
%
37.2
38.3
0.58
137
1789
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
63
965
0.61
3.44
2.5
3.3
ug/l
0.9
0.9
0.12
41
686
(3000963) Hemoglobin [Mass/volume] in Blood
326
3681
0.72
3.44
33.7
24.6
g/l
130.7
132.2
0.91
315
3579
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
37
196
1.95
3.43
9.7
7.9
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
326
3680
0.72
3.43
33.5
24.5
e12/l
4.4
4.4
0.06
312
3527
(3035941) MCH [Entitic mass]
326
3680
0.72
3.43
33.4
24.4
pg
30.3
30.4
0.79
316
3581
(3007461) Platelets [#/volume] in Blood
326
3678
0.72
3.40
33.5
24.5
e9/l
238.4
234.9
0.43
314
3541
(3024731) MCV [Entitic volume]
326
3678
0.72
3.40
33.4
24.4
fl
91.5
91.8
0.45
316
3580
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
268
3117
0.73
3.38
22.6
16.2
ml/min/173m2
71.2
71.0
0.06
224
2601
(3010813) Leukocytes [#/volume] in Blood
327
3681
0.73
3.30
33.4
24.5
e9/l
7.3
6.9
2.21
313
3531
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
131
1701
0.70
3.19
4.6
5.7
ug/l
3.5
3.7
0.05
119
1464
(3051593) INR in Capillary blood by Coagulation assay
7
12
5.89
3.03
30.7
23.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
100
1353
0.68
3.02
4.7
4.8
%
22.3
21.9
0.10
54
718
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
281
3217
0.74
3.02
5.3
4.9
mmol/l
6.2
6.1
0.64
259
2836
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
314
3530
0.74
2.93
12.1
10.3
u/l
26.4
24.2
0.45
299
3351
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
17
4.76
2.93
2.8
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
50
309
1.68
2.85
4.2
3.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
284
3224
0.75
2.73
6.2
5.1
mmol/l
2.2
2.6
9.87
268
2850
(4306422)
7
16
4.42
2.48
1.1
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
17
4.16
2.36
1.1
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
278
3125
0.78
2.26
5.6
4.5
mmol/l
4.1
4.4
7.71
262
2785
(3039443) Prostate specific Ag panel - Serum or Plasma
0
60
0.00
2.25
0.0
1.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
325
3580
0.78
2.23
29.0
20.2
mmol/l
139.5
139.6
0.24
312
3456
(3002032) Base excess in Venous blood by calculation
56
382
1.52
2.17
3.2
3.5
mmol/l
1.7
2.1
0.38
45
299
(21494890) Protein electrophoresis panel - 24 hour Urine
9
30
3.03
2.15
3.1
1.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
326
3582
0.78
2.14
29.3
20.4
mmol/l
4.0
4.0
0.19
312
3458
(3013512) EKG study
92
1195
0.72
2.13
7.5
4.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
101
775
1.37
2.10
6.1
4.0
ng/l
118.7
275.7
1.32
83
668
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
275
3079
0.79
2.09
5.5
4.5
mmol/l
1.3
1.4
4.44
259
2718
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
10
5.03
2.07
1.4
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
67
479
1.45
2.07
7.3
6.0
mmol/l
1.2
1.6
0.31
54
359
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
55
378
1.51
2.06
3.0
2.6
ug/l
6.9
6.8
0.01
48
323
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
55
378
1.51
2.06
3.9
3.4
ng/l
276.2
286.1
0.04
48
346
(3026008) Bacteria identified in Urine by Culture
151
1234
1.31
2.05
3.4
3.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
45
297
1.56
2.03
1.9
1.6
—
—
—
0
0
(3012544) pH of Venous blood
57
397
1.49
2.01
3.5
3.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
32
194
1.69
2.01
1.2
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
103
1304
0.74
2.01
2.0
2.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
316
3473
0.79
2.01
23.4
16.4
—
—
—
0
0
(3002256) Pathology report gross observation
29
462
0.61
1.88
1.2
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
53
0.00
1.88
0.0
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
13
3.87
1.72
1.4
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
89
692
1.34
1.71
1.6
1.6
mg/l
1.5
1.5
0.00
70
547
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
313
3415
0.81
1.71
24.5
16.9
mg/l
26.6
28.1
0.37
274
2786
(3017704) Immunofixation for Urine
7
25
2.82
1.65
1.1
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
49
2.27
1.64
2.2
6.5
iu/ml
—
153.3
—
0
7
(4268621)
5
14
3.59
1.62
1.8
2.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
72
931
0.74
1.61
3.9
3.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
37
249
1.52
1.57
4.4
4.1
mmol/l
3.1
2.3
0.46
30
190
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
43
0.00
1.52
0.0
2.9
—
40.7
—
0
43
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
184
1594
1.23
1.50
4.4
4.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
8
167
0.47
1.49
2.1
3.1
u/ml
44779.1
1833.5
—
8
141
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
188
1633
1.23
1.49
6.9
4.1
ng/l
73.2
72.1
0.01
155
1261
(3044242) Glucose [Moles/volume] in Arterial blood
7
28
2.52
1.45
2.3
1.9
—
—
—
0
0
(4024509)
7
28
2.52
1.45
2.3
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
226
2522
0.82
1.44
4.6
3.8
mm/h
15.1
15.2
0.05
212
2261
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
39
2.33
1.43
1.1
1.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
41
289
1.45
1.41
4.8
3.8
ng/l
121.1
96.7
0.53
35
255
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
284
3098
0.83
1.41
7.2
6.3
mmol/mol
42.7
41.2
1.38
264
2793
(3026389) Candida sp identified in Specimen by Organism specific culture
9
40
2.27
1.40
2.1
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
29
2.43
1.39
1.0
1.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
58
438
1.36
1.37
2.5
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
116
964
1.26
1.36
5.1
4.4
estimate
0.0
0.0
0.00
35
305
(3025130) Human papilloma virus identified in Specimen
5
17
2.96
1.36
2.2
2.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
17
2.96
1.36
1.4
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
272
2973
0.83
1.36
4.9
4.0
mmol/l
1.4
1.2
2.80
257
2603
(3005570) Glucose [Moles/volume] in Urine
10
47
2.15
1.34
2.2
2.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
79
628
1.30
1.32
34.4
29.4
inr
1.7
1.4
0.51
12
81
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
129
1.65
1.32
3.0
2.3
u/ml
0.4
0.3
0.35
11
73
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
28
187
1.52
1.26
1.9
2.4
%
0.7
0.7
0.08
28
181
(3030467) Casts [#/volume] in Urine by Automated count
94
1135
0.79
1.26
4.0
3.5
e6/l
0.7
0.5
0.19
74
894
(3003338) MCHC [Mass/volume]
243
2670
0.84
1.25
29.7
22.2
g/l
330.6
331.2
0.39
237
2632
(3023368) Bacteria identified in Blood by Culture
144
1240
1.22
1.22
3.9
4.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
35
247
1.45
1.22
3.4
3.6
%
1.2
0.1
0.40
13
75
(3044889) 12 lead EKG panel
220
2433
0.84
1.20
5.2
4.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
36
257
1.43
1.19
3.2
3.6
%
0.0
0.2
2.63
13
86
(3000764) Benzodiazepines [Presence] in Urine
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
34
0.00
1.16
0.0
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
69
550
1.29
1.15
2.1
1.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
276
2986
0.85
1.14
5.2
4.4
mu/l
1.9
2.0
0.53
254
2613
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
31
433
0.70
1.14
5.7
4.6
%
32.4
32.5
0.02
22
271
(40768800) Prostate Pathology biopsy report
5
113
0.44
1.14
1.0
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
22
328
0.66
1.13
5.1
4.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
40
2.01
1.12
2.1
1.9
—
—
—
0
0
(44806420)
5
21
2.39
1.09
2.4
2.4
—
—
—
0
0
(3004451) EKG impression Narrative
5
21
2.39
1.09
1.0
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
21
2.39
1.09
1.4
1.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
62
773
0.78
1.09
2.3
3.2
mmol/l
2.5
2.5
0.07
53
661
(3021901) Oxygen saturation in Capillary blood
15
89
1.70
1.08
3.4
2.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
11
59
1.88
1.08
1.9
2.1
%
60.2
57.5
0.15
11
59
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
143
1626
0.84
1.05
2.2
2.1
pmol/l
95.7
92.7
0.33
86
853
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
148
0.53
1.05
2.6
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
83
1.70
1.02
1.4
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
33
241
1.39
0.99
1.7
1.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
23
2.18
0.98
1.4
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
30
0.00
0.97
0.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
36
1.96
0.97
1.0
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
14
85
1.66
0.95
1.3
1.2
—
2.6
—
0
7
(3017181) Myelocytes/100 leukocytes in Blood
37
278
1.35
0.95
3.1
3.6
%
0.6
0.8
0.40
14
95
(3039162) Centromere protein B Ab [Units/volume] in Serum
6
27
2.24
0.93
1.2
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
107
923
1.20
0.90
1.9
1.8
pmol/l
406.2
7672035.5
0.50
95
743
(3049717) Cytology report of Urine Cyto stain
14
217
0.64
0.89
3.2
3.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
108
934
1.19
0.88
1.8
1.8
nmol/l
1156.6
1185.7
0.13
84
685
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
6
30
2.01
0.87
1.5
1.3
—
68.0
—
0
5
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
64
1.73
0.86
1.3
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
110
956
1.19
0.86
4.7
3.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
72
1.68
0.85
1.4
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
36
275
1.33
0.84
3.0
2.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
31
1.95
0.84
4.2
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
45
1.79
0.84
1.1
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
45
1.79
0.84
1.8
3.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
33
249
1.35
0.84
3.3
3.5
%
0.6
0.6
0.01
12
74
(3026493) Urate [Moles/volume] in Serum or Plasma
111
972
1.18
0.80
3.0
2.8
umol/l
8740.8
6413.4
0.14
93
813
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
44
350
1.28
0.79
1.5
1.3
titre
280.0
451.3
0.97
14
78
(3026470) Cobalt [Mass/volume] in Blood
0
26
0.00
0.78
0.0
2.0
—
3.9
—
0
21
(3020891) Body temperature
23
166
1.40
0.77
3.2
3.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
149
1.43
0.76
3.7
2.2
g/l
3.8
3.8
0.01
13
106
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
222
2391
0.88
0.76
4.3
3.6
pmol/l
15.2
15.0
0.35
204
2090
(3002582) Erythrocytes [#/volume] in Urine
111
1255
0.86
0.76
4.0
3.6
e6/l
44.7
76.2
0.74
89
1009
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
141
1.43
0.75
3.9
2.3
g/l
3.8
3.3
0.56
13
108
(4035726)
22
300
0.72
0.75
1.3
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
54
652
0.81
0.75
3.3
3.1
e6/l
1.4
1.0
0.27
33
392
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
150
1.42
0.74
3.7
2.2
g/l
8.2
7.6
0.37
13
111
(40768797) Stomach Pathology biopsy report
52
426
1.24
0.74
1.2
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
38
1.85
0.73
1.1
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
34
264
1.31
0.73
1.6
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
20
142
1.42
0.73
2.5
3.0
g/l
0.3
0.3
—
8
46
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
20
142
1.42
0.73
3.4
3.1
pmol/l
4.3
4.3
0.03
20
123
(3017569) Oxygen content in Arterial blood
5
25
2.01
0.73
4.2
2.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
10
60
1.68
0.72
1.2
1.1
nmol/l
0.9
0.8
—
10
51
(3021960) Folate [Moles/volume] in Serum or Plasma
88
1008
0.85
0.71
1.7
1.6
nmol/l
16.5
20.0
2.17
81
843
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
12
77
1.57
0.69
1.1
1.0
—
8.4
—
0
6
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
61
1.65
0.69
1.1
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
258
2741
0.89
0.69
7.8
7.2
u/l
88.0
81.7
0.55
244
2530
(3016750) Collection duration of Urine
5
27
1.86
0.68
1.8
2.6
min
602.2
495.2
—
5
17
(3015377) Calcium [Moles/volume] in Serum or Plasma
116
1296
0.87
0.68
2.9
3.2
mmol/l
2.3
2.3
0.90
98
1103
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
53
633
0.82
0.68
3.4
3.3
e6/l
1.6
2.1
0.35
32
378
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
136
1.41
0.67
1.7
2.3
g/l
9.8
10.8
0.35
14
114
(3000991) Gas panel - Venous blood
40
323
1.26
0.66
8.7
7.0
—
—
—
0
0
(3026782) Osmolality of Urine
98
865
1.16
0.65
2.8
3.0
mosm/kgh2o
521.4
567.2
1.30
74
727
(3013139) Helicobacter pylori Ag [Presence] in Stool
23
172
1.35
0.64
1.2
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
129
0.61
0.64
1.5
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
205
1905
1.12
0.63
5.0
5.9
umol/l
12.9
12.5
0.10
200
1793
(40760892) CBC W Ordered Manual Differential panel - Blood
56
660
0.83
0.63
5.2
4.6
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
6
103
0.58
0.62
1.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
49
1.64
0.62
1.4
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
67
578
1.18
0.59
2.6
2.5
%
21.4
22.2
0.18
53
499
(36304419) Bacteria [Presence] in Urine
96
1075
0.87
0.59
3.9
3.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
207
1932
1.11
0.58
7.6
6.2
mmol/l
1.2
1.2
0.66
187
1575
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
114
1028
1.14
0.57
3.3
2.9
u/l
32.7
34.6
0.24
105
979
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
150
1.35
0.56
3.8
2.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
38
459
0.82
0.56
10.4
9.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
6
37
1.63
0.55
2.2
2.5
ml
548.5
609.8
—
6
22
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
9
60
1.51
0.54
1.1
1.1
u/l
20.5
34.9
—
9
50
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
133
1445
0.90
0.51
4.0
3.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
183
1711
1.10
0.49
5.1
4.0
estimate
0.0
0.0
0.00
35
324
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
46
1.53
0.48
4.0
4.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
46
1.53
0.48
1.3
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
80
714
1.14
0.48
2.0
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
18
137
1.32
0.48
1.1
1.1
iu/ml
454.6
165.6
—
5
41
(3002385) Erythrocyte distribution width [Ratio]
256
2684
0.91
0.47
27.1
20.5
%
14.1
14.0
0.39
251
2611
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
22
276
0.79
0.46
1.7
3.0
ml/min/173m2
50.5
56.9
—
6
121
(3052851) Hemolysis interference index of Serum or Plasma
8
119
0.67
0.46
5.4
3.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
146
1356
1.10
0.45
5.6
4.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
117
1074
1.11
0.45
4.0
3.2
mg/l
2241.7
215.8
1.20
83
716
(3027945) Reticulocytes/100 erythrocytes in Blood
57
500
1.16
0.44
2.3
2.4
%
1.7
1.8
0.23
51
435
(3021601) Nitrite [Presence] in Urine by Test strip
182
1713
1.09
0.43
6.8
5.5
estimate
0.0
0.0
0.00
38
316
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
21
261
0.80
0.42
1.3
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
42
362
1.17
0.41
2.7
2.6
e9/l
71.3
68.7
0.19
33
287
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
17
0.00
0.40
0.0
1.7
—
14.4
—
0
17
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.3
—
0.1
—
0
12
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
18
0.00
0.40
0.0
1.1
—
10.8
—
0
7
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
3.2
—
90.3
—
0
18
(3022313) Gas panel - Capillary blood
24
196
1.23
0.39
4.7
4.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
38
441
0.85
0.39
5.4
3.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
63
562
1.14
0.39
1.2
1.2
u/ml
0.7
0.9
0.68
16
118
(3019832) Treponema pallidum Ab [Presence] in Serum
7
105
0.66
0.39
1.3
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
57
505
1.14
0.39
1.9
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
31
261
1.20
0.39
1.3
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
33
280
1.19
0.38
1.4
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
98
1.33
0.37
1.0
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
13
98
1.33
0.37
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
13
98
1.33
0.37
1.3
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
37
1.35
0.37
1.0
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
74
814
0.89
0.37
1.8
1.6
mmol/l
1.4
1.3
0.42
66
648
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
70
1.29
0.37
1.1
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
85
778
1.11
0.36
6.7
4.5
kg/l
1.0
1.0
0.01
25
130
(3018095) Leukocytes [#/volume] in Urine
132
1408
0.92
0.36
4.5
4.0
e6/l
59.6
172.4
1.40
95
1075
(42529406) Shigella sp [Presence] in Stool by Culture
13
99
1.32
0.35
1.0
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
9
121
0.74
0.35
1.9
2.8
u/ml
12.4
42.8
—
9
113
(3022621) pH of Urine by Test strip
31
264
1.18
0.35
3.4
3.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
136
1447
0.92
0.35
3.1
2.7
ug/l
128.4
163.7
1.43
129
1289
(3020682) Albumin/Creatinine [Ratio] in Urine
123
1150
1.09
0.34
4.0
4.0
mg/mmol
13.8
9.6
0.47
85
748
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
56
502
1.13
0.34
1.9
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
22
264
0.83
0.34
2.0
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
151
1594
0.93
0.32
2.8
2.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
38
334
1.15
0.31
1.6
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
25
212
1.19
0.30
1.6
1.8
g/l
1.8
1.5
0.63
20
185
(40768793) Breast Pathology biopsy report
7
54
1.30
0.30
1.4
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
93
1.30
0.30
1.2
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
55
1.28
0.30
1.1
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
39
345
1.14
0.29
2.1
2.0
g/l
0.2
0.2
0.26
34
314
(3025941) Bacteria identified in Stool by Culture
21
176
1.20
0.29
1.1
1.2
—
—
—
0
0
(3019225) pH of Specimen
33
375
0.87
0.28
4.8
4.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
103
1.27
0.28
2.8
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
12
94
1.28
0.28
6.1
3.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
118
0.76
0.27
1.7
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
71
0.70
0.26
1.4
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
75
1.20
0.25
1.7
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
181
1740
1.06
0.24
5.2
4.1
estimate
0.0
0.0
0.00
36
313
(3024928) Oxygen saturation in Venous blood
10
78
1.29
0.24
3.4
2.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
93
0.75
0.22
1.1
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
144
1.19
0.22
1.9
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
41
1.22
0.22
1.2
1.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
187
1936
0.95
0.22
7.5
8.1
e9/l
4.7
4.4
0.75
161
1674
(3023511) Choriogonadotropin [Units/volume] in Urine
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
(4015189)
0
10
0.00
0.21
0.0
2.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
98
1.23
0.21
1.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.0
—
1.0
—
0
7
(3036670) Protein [Mass/volume] in Synovial fluid
0
12
0.00
0.21
0.0
1.2
—
34.9
—
0
6
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.1
—
0.8
—
0
7
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
14
0.00
0.20
0.0
1.5
—
71.0
—
0
14
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.9
—
875.1
—
0
14
(3014891) Appearance of Pleural fluid
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
52
1.16
0.19
1.8
2.0
%
87.9
88.4
—
6
52
(3021589) Normoblasts [#/volume] in Blood
152
1465
1.05
0.19
12.3
10.2
e9/l
0.0
0.0
0.65
128
1199
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
58
1.21
0.18
1.1
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
185
1905
0.96
0.17
4.0
3.0
u/l
67.0
55.0
0.68
171
1723
(40768443) Skin Pathology biopsy report
14
163
0.86
0.17
1.3
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
154
1489
1.05
0.17
5.9
5.2
%
0.6
0.6
0.33
143
1364
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
129
1.17
0.17
1.5
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
19
167
1.14
0.17
2.1
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
68
0.73
0.17
1.0
1.6
—
—
—
0
0
(1002224) Polysomnography panel
8
70
1.14
0.16
1.1
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
92
1.20
0.16
1.2
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
92
1.20
0.16
1.5
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
80
839
0.95
0.15
6.4
5.8
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
9
80
1.13
0.15
1.1
2.0
mg/l
11.8
12.7
—
9
72
(3018418) pH of Serum or Plasma
113
1173
0.95
0.15
4.6
3.6
ph
7.4
7.4
0.49
22
221
(3006315) Basophils [#/volume] in Blood
157
1617
0.96
0.15
5.8
5.0
e9/l
0.0
0.0
0.16
133
1381
(3018010) Neutrophils/100 leukocytes in Blood
157
1524
1.04
0.15
5.7
5.3
%
59.7
58.9
0.37
144
1395
(3014051) Protein [Presence] in Urine by Test strip
7
86
0.81
0.14
1.6
2.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
240
2449
0.96
0.14
5.4
4.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
38
353
1.08
0.14
1.3
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
160
1.13
0.14
2.1
3.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
164
1685
0.96
0.14
5.7
5.1
e9/l
0.2
0.2
0.33
144
1472
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
88
844
1.05
0.14
2.6
2.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
108
0.83
0.13
2.1
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
16
142
1.13
0.12
1.4
2.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
112
1084
1.04
0.12
3.4
3.1
mmol/l
7.5
7.3
0.21
92
886
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
181
1769
1.03
0.12
7.0
5.3
mmol/l
1.2
1.2
1.70
170
1562
(3019198) Lymphocytes [#/volume] in Blood
161
1649
0.97
0.12
5.8
5.2
e9/l
1.7
1.8
0.81
140
1445
(3001604) Monocytes [#/volume] in Blood
157
1608
0.97
0.11
5.7
5.0
e9/l
0.6
0.6
0.01
132
1366
(46235355) HIV 1 and 2 tests - Meaningful Use set
34
318
1.07
0.11
1.4
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
124
1.13
0.11
1.0
1.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
157
1534
1.03
0.11
6.0
5.5
%
8.7
9.1
0.68
145
1418
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
44
1.14
0.10
1.6
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
156
1527
1.03
0.10
5.9
5.2
%
2.7
2.8
0.18
144
1402
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
146
1428
1.03
0.09
4.3
3.3
ng/l
2663.4
2244.3
0.31
132
1241
(3003434) Protein [Mass/volume] in Pleural fluid
10
87
1.15
0.09
1.7
1.5
g/l
25.9
29.3
—
10
80
(3011397) Hemoglobin [Presence] in Urine by Test strip
80
776
1.04
0.08
4.9
4.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
60
0.83
0.08
3.8
1.8
pg
32.4
32.7
—
5
60
(3008898) HLA-B27 [Presence]
5
63
0.79
0.08
1.2
1.1
—
—
—
0
0
(4094501)
7
64
1.09
0.08
1.3
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
65
1.08
0.08
1.1
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
67
1.05
0.08
2.6
2.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
134
1367
0.97
0.08
2.8
2.1
nmol/l
76.2
79.3
0.54
118
1176
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
71
0.84
0.07
1.3
1.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
8
76
1.05
0.07
1.4
2.2
g/l
4.6
3.7
—
8
70
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
22
206
1.07
0.07
2.5
2.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
31
326
0.95
0.07
3.4
3.6
—
—
—
0
0
(4010399)
20
214
0.93
0.07
1.4
1.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
159
1565
1.02
0.07
6.1
5.5
%
25.2
25.4
0.10
145
1426
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
91
0.88
0.07
1.1
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
92
0.87
0.07
1.6
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
103
0.87
0.06
6.7
3.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
18
168
1.07
0.06
1.0
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
129
1.09
0.05
1.2
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
247
2449
1.02
0.05
5.7
5.0
e6/l
10209.2
1983.2
—
5
50
(3000492) Spirometry study
27
258
1.05
0.05
1.4
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
101
1.09
0.04
1.5
1.4
—
—
—
0
0
(4034850)
12
111
1.08
0.04
12.3
11.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
90
914
0.98
0.03
3.2
2.8
e6/l
6.3
4.4
0.74
74
800
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
109
1076
1.02
0.03
2.4
2.1
mg/l
3.5
3.3
0.28
97
897
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
19
199
0.95
0.03
13.4
8.2
mmol/l
24.5
25.0
0.18
19
177
(3003694) ABO and Rh group [Type] in Blood
79
801
0.98
0.02
1.2
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
113
1141
0.99
0.02
2.7
2.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
42
428
0.98
0.01
1.3
1.3
u/ml
1.6
11.6
2.13
14
149
(3024561) Albumin [Mass/volume] in Serum or Plasma
167
1662
1.01
0.01
5.1
4.5
g/l
33.1
34.5
2.01
155
1523
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
15
156
0.96
0.00
1.7
1.3
—
42.1
—
0
6
(3000330) Specific gravity of Urine by Test strip
23
224
1.03
0.00
3.5
4.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
13
134
0.97
0.00
3.7
5.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
25
245
1.02
0.00
3.0
3.0
e6/l
0.1
0.3
1.49
25
240
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
133
0.98
0.00
1.1
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
52
516
1.01
0.00
1.4
1.4
g/l
2.3
2.6
0.65
36
295
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
44
442
1.00
0.00
1.4
1.3
iu/ml
24.3
38.3
0.77
13
150
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
119
1.01
0.00
1.2
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
113
1132
1.00
0.00
6.0
5.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
38
379
1.00
0.00
1.4
1.4
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
70
1.00
0.00
7.3
3.0
e9/l
5.0
4.7
—
7
70
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
37.6
—
0
8
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.4
—
0.7
—
0
8
(3022689) Creatine [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.2
—
127.7
—
0
6
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
2.0
—
3094.2
—
0
6
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
54
0.93
0.00
1.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
3.2
—
0
6
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
1.6
—
0
8
(3000285) Sodium [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
7
0.00
0.00
0.0
1.1
—
4.4
—
0
7
(21494814) CD8 cells/100 lymphocytes in Specimen
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
56
0.89
0.00
1.2
1.4
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
0
5
0.00
0.00
0.0
30.0
—
8.2
—
0
5
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
110.3
—
0
5
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.1
—
0
5
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
0.00
0.0
5.0
—
104.7
—
0
7
(4133840)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
65
0.92
0.00
1.3
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
1.9
—
0
7
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
79
0.88
0.00
2.3
1.8
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
73
0.96
0.00
9.7
3.5
%
62.3
60.0
—
7
73
(3042631) Mycobacterium sp identified in Specimen
6
69
0.87
0.00
1.8
3.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
55
0.91
0.00
1.0
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
62
0.97
0.00
1.2
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
66
0.91
0.00
1.2
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
53
0.94
0.00
1.2
2.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
65
0.92
0.00
1.8
3.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
52
0.96
0.00
1.2
1.3
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
17.2
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint I9_STENOSIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_STENOSIS | 1.749 [1.52, 2.02] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.296 |
During the follow-up period (1.1.1998 — 31.12.2019), 656 out of 1237 females with I9_STENOSIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_STENOSIS | 1.811 [1.56, 2.1] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.008 |
During the follow-up period (1.1.1998 — 31.12.2019), 719 out of 1395 males with I9_STENOSIS died.
Mortality risk
Mortality risk for people of age
years, who have I9_STENOSIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.192% | 0.308% |
| 5 | 1.036% | 2.107% |
| 10 | 2.553% | 5.306% |
| 15 | 4.843% | 9.863% |
| 20 | 8.837% | 16.834% |
Relationships between endpoints
↥Index endpoint: I9_STENOSIS – Occlusion and stenosis of arteries, not leading to stroke
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data